The corporate aims to boost its financial investment in biotechnology and biosimilars, targeting an approximate sector worth of USD twenty five billion in India by 2025. Wockhardt's initiatives to scale up manufacturing abilities are apparent, with strategies to enhance production ability by thirty% more than the subsequent two a long https://freebookmarkpost.com/story19878735/little-known-facts-about-promethazine-codeine